Boc-L-cysteine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-L-cysteine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-002764
CAS number
20887-95-0
Molecular Formula
C8H15NO4S
Molecular Weight
221.30
Boc-L-cysteine
IUPAC Name
(2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-sulfanylpropanoic acid
Synonyms
Boc-L-Cys-OH; N-tert-Butyloxycarbonylcysteine
Appearance
White crystalline powder
Purity
98.5-100.5% (Assay by titration)
Density
1.215 g/cm3
Melting Point
65-76 °C
Boiling Point
361.4±37.0 °C(Predicted)
Storage
Store at 2-8 °C
InChI
InChI=1S/C8H15NO4S/c1-8(2,3)13-7(12)9-5(4-14)6(10)11/h5,14H,4H2,1-3H3,(H,9,12)(H,10,11)/t5-/m0/s1
InChI Key
ATVFTGTXIUDKIZ-YFKPBYRVSA-N
Canonical SMILES
CC(C)(C)OC(=O)NC(CS)C(=O)O

Boc-L-cysteine, a derivative of the amino acid cysteine, holds a pivotal role in both biochemical research and pharmaceutical development. Here are four key applications of Boc-L-cysteine:

Peptide Synthesis: Serving as a fundamental component in solid-phase peptide synthesis, Boc-L-cysteine distinguishes itself through the shielding of its thiol group, facilitating precise modifications while preventing the unwanted formation of disulfide bonds. Upon the completion of peptide assembly, the strategic removal of the acidic Boc group reveals the functional cysteine residue, unleashing a realm of peptide possibilities teeming with complexity and intricacy.

Drug Development: Positioned at the forefront of pharmaceutical innovation, Boc-L-cysteine emerges as a crucial intermediary in the synthesis of a myriad of drug compounds. Its utilization ensures the stability and proper conformation of the cysteine moiety within intricate drug structures, a necessity particularly vital in crafting cysteine-based enzyme inhibitors and other therapeutic wonders that delve deep into the realm of pharmaceutical sophistication.

Structural Biology: Venturing into the intricate domain of structural biology, Boc-L-cysteine assumes a central role in preparing proteins and peptides for detailed structural analyses, such as X-ray crystallography and NMR spectroscopy. Through the meticulous deprotection of the shielded cysteine, researchers can introduce specific isotopes or labels, further unraveling the convoluted web of protein interactions at a molecular level, unveiling a world of structural complexity with a burst of profound insights.

Bioconjugation: Embracing the art of bioconjugation methodologies, Boc-L-cysteine emerges as a cornerstone in attaching an array of functional groups to peptides and proteins with unparalleled finesse. Once liberated from its protective shield, the thiol group forges enduring connections with maleimide, iodoacetate, and various other thiol-reactive entities, showcasing its prowess in shaping targeted drug delivery systems and diagnostic innovations steeped in complexity and precision.

1.Bound fumonisin B1: analysis of fumonisin-B1 glyco and amino acid conjugates by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Seefelder W1, Knecht A, Humpf HU. J Agric Food Chem. 2003 Aug 27;51(18):5567-73.
To study the formation of fumonisin artifacts and the binding of fumonisins to matrix components (e.g., saccharides and proteins) in thermal-treated food, model experiments were performed. Fumonisin B(1) and hydrolyzed fumonisin B(1) were incubated with alpha-d-glucose and sucrose (mono- and disaccharide models), with methyl alpha-d-glucopyranoside (starch model), and with the amino acid derivatives N-alpha-acetyl-l-lysine methyl ester and BOC-l-cysteine methyl ester (protein models). The reaction products formed were analyzed by liquid chromatography-electrospray ionization-tandem mass spectrometry. The incubation of d-glucose with fumonisin B(1) or hydrolyzed fumonisin B(1) resulted in the formation of Amadori rearrangement products. Whereas conjugates were found following the reaction of sucrose, methyl alpha-d-glucopyranoside, and the amino acid derivatives with fumonisin B(1), the heating with hydrolyzed fumonisin B(1) yielded no artifacts.
2.Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde.
Hashimoto A1, Nishikawa T, Oka T, Takahashi K, Hayashi T. J Chromatogr. 1992 Nov 6;582(1-2):41-8.
The concurrent determination of free amino acid enantiomers and non-chiral amino acids in rat brain and serum was accomplished by high-performance liquid chromatography with fluorimetric detection after derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde. The method revealed the presence of a large amount of free D-serine (0.22 mumol/g of tissue; D/D + L ratio = 0.25) in the brain whereas D-aspartate and D-alanine were established to be at trace levels. These results further support the presence of D-serine in adult brain tissues as demonstrated by recent work using gas chromatography.
3.High-performance liquid chromatographic determination of enantiomeric amino acids and amino alcohols after derivatization with o-phthaldialdehyde and various chiral mercaptans. Application to peptide hydrolysates.
Buck RH, Krummen K. J Chromatogr. 1987 Jan 30;387:255-65.
o-Phthaldialdehyde in combination with a chiral mercaptan is a powerful chiral reagent for the pre-column derivatization of many enantiomeric compounds bearing primary amino groups. The diastereoisomers formed can efficiently be resolved on conventional reversed-phase columns. Simultaneous determination of the enantiomers of various amino acids, amino alcohols and biogenic amines was achieved by gradient elution and fluorescence detection. The resolution was optimized by varying the chiral mercaptan in the reagent, Boc-L-cysteine, N-acetyl-L-cysteine and N-acetyl-D-penicillamine being used for this purpose. The resolutions were calculated. Most of the enantiomers showed good resolution with each of the three chiral mercaptans, whereas some enantiomers were only separable by one or two of them. The method was applied to the analysis of peptide hydrolysates. The composition of peptides bearing L- and D-amino acids and an amino alcohol was determined.
4.Investigation of the coordination interactions of S-(pyridin-2-ylmethyl)-L-cysteine ligands with M(CO)(3)(+) (M = Re, (99m)Tc).
He H1, Morley JE, Twamley B, Groeneman RH, Bucar DK, MacGillivray LR, Benny PD. Inorg Chem. 2009 Nov 16;48(22):10625-34. doi: 10.1021/ic901159r.
Development of new ligands for fac-M(OH(2))(3)(CO)(3)(+) (M = Re, (99m)Tc) led the investigation with S-(pyridin-2-ylmethyl)-l-cysteine, 1. The ligand 1 has potential to coordinate with the metal through three different tridentate modes: tripodal through cysteine (O,N,S) and two linear involving the S-pyridyl and cysteine (O,S,N(Py), N,S,N(Py)). From the reaction with 1, two species were observed in the (1)H NMR, where the primary product was the linear fac-Re(N,S,N(Py)-1)(CO)(3)(+), 2a, complex. To identify the coordination mode of the minor product, functionalized analogues of 1 were prepared from S-(pyridin-2-ylmethyl)-Boc-l-cysteine-methyl ester, 3, with orthogonal protecting groups on the C terminus (methyl ester) in S-(pyridin-2-ylmethyl)-l-cysteine methyl ester, 4, or N terminus (Boc) in S-(pyridin-2-ylmethyl)-Boc-l-cysteine, 6, that specifically directed the coordination mode of fac-M(H(2)O)(3)(CO)(3)(+) to either N,S,N(Py) or O,S,N(Py), respectively.
Online Inquiry
Verification code
Inquiry Basket